WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'4001 Infant (under 12 months) mortality rate: 172
GDP / capita (US$): 3'6351 Child (under 5 years) mortality rate: 222

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 90'796  89'914  89'047  88'200  87'369  80'888  68'910  54'897 
Births 1'440  1'453  1'464  1'470  1'470  1'403  1'986  1'771 
Surviving infants 1'419  1'432  1'442  1'447  1'447  1'371  1'916  1'695 
Pop. less than 5 years 7'184  7'222  7'229  7'245  7'312  7'128  9'315  8'080 
Pop. less than 15 years 20'750  20'777  20'918  21'192  21'637  25'544  25'778  22'466 
Female 15-49 years 26'003  25'910  25'752  25'565  25'292  22'125  16'867  12'486 

Number of reported case

(Click for retrospective incidence data for Viet Nam)
Diphtheria 12  13  17  113  509  1'730 
Japanese encephalitis 183  126  140  68  17 
Measles 578  750  2'809  6'582  352  16'512  8'175  86'901 
Mumps
Pertussis 98  105  81  122  280  1'426  4'095  96'577 
Polio* 723  1'741 
Rubella 185  7'259  2'300  1'573  873 
Rubella (CRS) 92  189 
Tetanus (neonatal) 39  32  35  33  34  142  313 
Tetanus (total) 253  186  196  247  221  267  628  1'948 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Viet Nam)
Vaccine year result method % card seen                                                
BCG 2009  96  MICS   51.6  98  98  94  97  92  98  90 
DTP1 2009  94  MICS   51.6  99  97  93  97  90  97 
DTP3 2009  74  MICS   51.6  97  95  93  96  93  96  88 
HepB_BD          76  55  21  40  25 
HepB3 2009  56  MICS   51.6  97  95  88  94  87  94 
Hib3          97  95  63 
JapEnc          94  93  88 
MCV 2009  92  MICS   51.6  96  96  98  97  92  97  88 
MCV2          83  93  98  96  97 
PCV1         
PCV3         
Pol3 2009  69  MICS   51.6  97  96  94  97  93  96  88 
Rota1         
Rota_last         
Rubella1         
TT2plus 2001  71  DHS   39.9  95  95  90  94  88  90  22 
PAB         
VAD1          98  80  90  88  67  77 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Viet Nam)
BCG 98  98  94  97  92  98  90 
DTP1 99  97  93  97  97  97  96 
DTP3 97  95  93  96  93  96  88 
HepB3 97  95  88  94  87 
Hib3 97  95  63 
MCV 96  96  98  97  92  97  88 
PAB 91  87  87  87  84  86  24 
PCV3
Pol3 97  96  94  97  93  96  88 
Rota_last

Number of districts in the country 697  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 88
From 80 to 89% 9
From 50 to 79% 3
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
CHOLERA No
DTwP 18 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB birth; Yes
JapEnc 12 months; + 2 weeks; 2 years; No
Measles 9, 18 months; Yes
OPV 2, 3, 4 months; Yes
TT pregnant Women; +1, +6 months; +1 year; Yes
Typhoid 3 years; No
VitaminA 6-11, 12-17, 18-23, 24-29, 30-36, 37-42 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2006 - 2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 10         

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 697  696  695  690  684  676  673 
Nº districts with DTP3 coverage >=80% number 676  657  662  668  666  654  658 
% of districts with DTP3 coverage >=80% From 0 to 100% 97  94  95  97  97  97  98 
Nº districts with measles (MCV1) coverage >=95% number 532  532  585  558  590     
% of districts with MCV1 coverage >=95% From 0 to 100% 76  76  84  81  86     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 34  30  28  80  88  87  80 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.